Venetoclax + Cytarabine Versus Idarubicin + Cytarabine : Efficacity Assessment as Post-remission Therapy to Elderly Patients With Acute Myeloid Leukemia in First Remission
Clinical trial NCT04968015 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04968015
- Sponsor
- French Innovative Leukemia Organisation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-25
- Primary completion
- 2025-08-15
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.